Structural insights reveal a recognition feature for tailoring hydrocarbon stapled-peptides against the eukaryotic translation initiation factor 4E protein.


Journal

Chemical science
ISSN: 2041-6520
Titre abrégé: Chem Sci
Pays: England
ID NLM: 101545951

Informations de publication

Date de publication:
28 Feb 2019
Historique:
received: 22 08 2018
accepted: 21 12 2018
entrez: 19 3 2019
pubmed: 19 3 2019
medline: 19 3 2019
Statut: epublish

Résumé

Stapled-peptides have emerged as an exciting class of molecules which can modulate protein-protein interactions. We have used a structure-guided approach to rationally develop a set of hydrocarbon stapled-peptides with high binding affinities and residence times against the oncogenic eukaryotic translation initiation factor 4E (eIF4E) protein. Crystal structures of these peptides in complex with eIF4E show that they form specific interactions with a region on the protein-binding interface of eIF4E which is distinct from the other well-established canonical interactions. This recognition element is a major molecular determinant underlying the improved binding kinetics of these peptides with eIF4E. The interactions were further exploited by designing features in the peptides to attenuate disorder and increase helicity which collectively resulted in the generation of a distinct class of hydrocarbon stapled-peptides targeting eIF4E. This study details new insights into the molecular basis of stapled-peptide: eIF4E interactions and their exploitation to enhance promising lead molecules for the development of stapled-peptide compounds for oncology.

Identifiants

pubmed: 30881679
doi: 10.1039/c8sc03759k
pii: c8sc03759k
pmc: PMC6385854
doi:

Types de publication

Journal Article

Langues

eng

Pagination

2489-2500

Références

Proteins. 2003 Feb 15;50(3):437-50
pubmed: 12557186
J Comput Chem. 2004 Jul 15;25(9):1157-74
pubmed: 15116359
Science. 2004 Sep 3;305(5689):1466-70
pubmed: 15353804
Proteins. 2006 Nov 15;65(3):712-25
pubmed: 16981200
Cell. 2007 Jan 26;128(2):257-67
pubmed: 17254965
J Mol Biol. 2007 Sep 7;372(1):7-15
pubmed: 17631896
J Biol Chem. 2009 Jun 19;284(25):16711-5
pubmed: 19237539
Cell Cycle. 2009 Jun 15;8(12):1905-11
pubmed: 19440045
J Appl Crystallogr. 2007 Aug 1;40(Pt 4):658-674
pubmed: 19461840
Acta Crystallogr D Biol Crystallogr. 2010 Jan;66(Pt 1):12-21
pubmed: 20057044
Acta Crystallogr D Biol Crystallogr. 2010 Feb;66(Pt 2):133-44
pubmed: 20124693
Acta Crystallogr D Biol Crystallogr. 2010 Apr;66(Pt 4):486-501
pubmed: 20383002
Clin Cancer Res. 2010 Oct 15;16(20):4914-20
pubmed: 20702611
Proc Natl Acad Sci U S A. 2011 Jan 18;108(3):1046-51
pubmed: 21191102
Acta Crystallogr D Biol Crystallogr. 2011 Apr;67(Pt 4):235-42
pubmed: 21460441
Acta Crystallogr D Biol Crystallogr. 2011 Apr;67(Pt 4):355-67
pubmed: 21460454
Retrovirology. 2011 May 03;8:28
pubmed: 21539734
Nucleic Acids Res. 2011 Jul;39(Web Server issue):W511-7
pubmed: 21609950
Clin Invest Med. 2011 Dec 01;34(6):E315
pubmed: 22129918
Br J Pharmacol. 2012 Jul;166(6):1846-59
pubmed: 22324512
J Med Chem. 2012 Apr 26;55(8):3837-51
pubmed: 22458568
Med Res Rev. 2012 Jul;32(4):786-814
pubmed: 22495651
Acta Crystallogr D Biol Crystallogr. 2012 Apr;68(Pt 4):352-67
pubmed: 22505256
Acta Crystallogr D Biol Crystallogr. 2012 Apr;68(Pt 4):431-40
pubmed: 22505263
PLoS One. 2012;7(10):e47235
pubmed: 23094039
Curr Pharm Des. 2013;19(16):2863-8
pubmed: 23140459
Sci Rep. 2013 Dec 13;3:3451
pubmed: 24336354
J Med Chem. 2014 Aug 14;57(15):6275-88
pubmed: 24601557
Chem Biol. 2014 Apr 24;21(4):441-452
pubmed: 24613018
Proc Natl Acad Sci U S A. 2014 Aug 5;111(31):E3187-95
pubmed: 25049413
Biochemistry. 2014 Aug 26;53(33):5461-70
pubmed: 25072107
Cancer Res. 2015 Jan 15;75(2):250-63
pubmed: 25593033
Bioorg Med Chem Lett. 2015;25(10):2019-27
pubmed: 25782745
ACS Chem Biol. 2015 Jun 19;10(6):1362-75
pubmed: 25798993
Nat Chem Biol. 2015 Jun;11(6):416-23
pubmed: 25894085
Oncotarget. 2015 Jun 20;6(17):15111-21
pubmed: 25915158
Nat Med. 2015 Jun;21(6):545
pubmed: 26046568
Biochemistry. 2015 Oct 27;54(42):6535-44
pubmed: 26427906
Nat Rev Drug Discov. 2016 Feb;15(2):87-95
pubmed: 26678621
J Hematol Oncol. 2017 Jul 3;10(1):133
pubmed: 28673313
Expert Opin Drug Discov. 2017 Nov;12(11):1117-1125
pubmed: 28889766

Auteurs

Dilraj Lama (D)

Bioinformatics Institute , ASTAR (Agency for Science, Technology and Research) , 30 Biopolis Street, #07-01 Matrix , Singapore 138671 . Email: chandra@bii.a-star.edu.sg ; Tel: +65 6478 8273.

Anne-Marie Liberatore (AM)

Ipsen Innovation , 5, Avenue du Canada , Les Ulis , France 91940 . Email: sergeauvin@gmail.com ; Tel: +33 160 922481.

Yuri Frosi (Y)

p53 Laboratory , ASTAR (Agency for Science, Technology and Research) , 8A Biomedical Grove, #06-04/05, Neuros/Immunos , Singapore 138648 . Email: cjbrown@p53lab.a-star.edu.sg ; Tel: +65 6478 8273.

Jessica Nakhle (J)

Ipsen Innovation , 5, Avenue du Canada , Les Ulis , France 91940 . Email: sergeauvin@gmail.com ; Tel: +33 160 922481.

Natia Tsomaia (N)

Ipsen Bioscience , 650 East Kendall Street , Cambridge , MA 02142 , USA.

Tarig Bashir (T)

Ipsen Innovation , 5, Avenue du Canada , Les Ulis , France 91940 . Email: sergeauvin@gmail.com ; Tel: +33 160 922481.

David P Lane (DP)

p53 Laboratory , ASTAR (Agency for Science, Technology and Research) , 8A Biomedical Grove, #06-04/05, Neuros/Immunos , Singapore 138648 . Email: cjbrown@p53lab.a-star.edu.sg ; Tel: +65 6478 8273.

Christopher J Brown (CJ)

p53 Laboratory , ASTAR (Agency for Science, Technology and Research) , 8A Biomedical Grove, #06-04/05, Neuros/Immunos , Singapore 138648 . Email: cjbrown@p53lab.a-star.edu.sg ; Tel: +65 6478 8273.

Chandra S Verma (CS)

Bioinformatics Institute , ASTAR (Agency for Science, Technology and Research) , 30 Biopolis Street, #07-01 Matrix , Singapore 138671 . Email: chandra@bii.a-star.edu.sg ; Tel: +65 6478 8273.
Department of Biological Sciences , National University of Singapore , 14 Science Drive 4 , Singapore 117543.
School of Biological Sciences , Nanyang Technological University , 50 Nanyang Drive , Singapore 637551.

Serge Auvin (S)

Ipsen Innovation , 5, Avenue du Canada , Les Ulis , France 91940 . Email: sergeauvin@gmail.com ; Tel: +33 160 922481.

Classifications MeSH